It is interesting to note that in the untreated fibroblasts of patients with sporadic PD, the expression of PAR2 was higher than in the controls, while it varied with the fibroblasts of patients with genetic PD, although in both groups of patients and also in the controls 1-PPA treatment determined a decrease in the expression of this receptor. This evidence concerns the gene F2RL1 and Parkinson disease.